POP-OUT | CLOSE
 
 
N-[(2R,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucine
 
EBT is found in 1 entries
EBT
  •   Chemical Component Summary   Hide
    Name N-[(2R,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucine
    Identifiers (2S)-2-[[(2R,3R)-3-azanyl-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid
    Synonyms Epibestatin
    Formula C16 H24 N2 O4
    Molecular Weight 308.37 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key VGGGPCQERPFHOB-HZSPNIEDSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB03424   (Different stereochemistry)
    Name Bestatin
    Groups experimental
    Description Bestatin is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
    Synonyms Ubenimex
    Brand names Bestatin
    Affected organism Humans and other mammals
    Indication An adjuvant therapy used for acute and chronic myelonous leukemia, lung cancer and nasopharyngeal cancer. It is also used to treat hypercholesterolaemia.
    Route of administration Oral
    Categories
    • Antineoplastic Agents
    • Immunosuppressive Agents
    • Hypolipidemic Agents
    CAS number 58970-76-6
    Targets
    Name Sequence search Pharmacological action Actions
    Bacterial leucyl aminopeptidase   Search  unknown
    Leukotriene A-4 hydrolase   Search  unknown
     
Ligand Image